The current Report "Belarus Pharmaceutical Country Report 2020 FY" ("Report") focuses on Belarus. The Report depicts the latest 2019-2020 FY business trends of the Belarussian pharmaceutical market and uncovers the market access pathway for pharmaceutical products: from marketing authorization to essential medicines and national formulary listings. It provides a forecast of total pharmaceutical market sales for the next three years (2021-2023), considering all the COVID-19-concerned crisis implications.
UPharma Consulting launches its updated series of pharmaceutical country reports covering all Eastern European, Central Asian, South Caucasian, CIS, and other countries. The current Report—Ukraine Pharmaceutical Country Report 2020 FY ("Report")—is focused on Ukraine. This publication depicts the latest 2019-2020 FY business trends of Ukraine's pharmaceutical market, uncovers the market access pathway for pharmaceutical products in the country: from marketing authorization to essential medicines and national formulary listings. It provides a forecast of total pharmaceutical market sales for the next three years (2021-2023), considering all the COVID-19-concerned crisis implications.
The presented Report uncovers the 2019 business trends of the pharmaceutical market of Ukraine and provides the forecast of its development for the next three years (2020-2022) considering all implications related to the COVID-19-concerned crisis. The publication also provides the most recent insight into the country’s socio-political development, including the anticipations regarding the country's economic prospects in 2020-2022. The Report also overviews Ukraine's healthcare system, portrays its epidemiology (including COVID-19 statistics) and demographics. It also depicts pharma regulation features in Ukraine including a step-by-step process of the marketing authorization for pharmaceutical products.
On this page, you will find a brief description of Ukraine's economy, pharmaceutical market, and healthcare system. The page contains interactive dashboards with relevant statistics.
"CIS Pharmaceutical Markets Landscape 2019" gives a general view of the pharmaceutical markets of 7 ex-Soviet countries by comparing the key indicators and describing the main pharmaceutical distributors. This publication will help you, having tested the main landscape, to get an idea of the surveyed markets, and maybe to determine a general plan for further access to them.Read more